Cost-effectiveness (CE) analysis of interferon-alpha in high-risk melanoma patients

被引：1
|
作者：
Ding, M
Xing, Y
Shih, T
Cox, D
Cantor, S
Cormier, J
机构：
[1] Rice Univ, Houston, TX 77251 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62070-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [31] Adjuvant treatment of high-risk melanoma - cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors
    Wahler, Steffen
    Mueller, Alfred
    Fuchs, Sabine
    von der Schulenburg, Johann-Matthias
    [J]. HEALTH ECONOMICS REVIEW, 2022, 12 (01)
  • [32] Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease
    Fonarow, Gregg C.
    van Hout, Ben
    Villa, Guillermo
    Arellano, Jorge
    Lindgren, Peter
    [J]. JAMA CARDIOLOGY, 2019, 4 (07) : 691 - 695
  • [33] Cost-effectiveness Analysis of Nutritional Support for the Prevention of Pressure Ulcers in High-Risk Hospitalized Patients
    Tuffaha, Haitham W.
    Roberts, Shelley
    Chaboyer, Wendy
    Gordon, Louisa G.
    Scuffham, Paul A.
    [J]. ADVANCES IN SKIN & WOUND CARE, 2016, 29 (06) : 261 - 267
  • [34] Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors
    Steffen Wahler
    Alfred Müller
    Sabine Fuchs
    Johann-Matthias von der Schulenburg
    [J]. Health Economics Review, 12
  • [35] Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
    Shuli Qu
    Xuedan You
    Tianyi Liu
    Lijiao Wang
    Zheng Yin
    Yanjun Liu
    Chong Ye
    Ting Yang
    Mao Huang
    Hongchao Li
    Liwen Fang
    Jinping Zheng
    [J]. npj Primary Care Respiratory Medicine, 31
  • [36] A Cost-Effectiveness Analysis of Postoperative Goal-Directed Therapy for High-Risk Surgical Patients
    Ebm, Claudia
    Cecconi, Maurizio
    Sutton, Les
    Rhodes, Andrew
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (05) : 1194 - 1203
  • [37] Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
    Qu, Shuli
    You, Xuedan
    Liu, Tianyi
    Wang, Lijiao
    Yin, Zheng
    Liu, Yanjun
    Ye, Chong
    Yang, Ting
    Huang, Mao
    Li, Hongchao
    Fang, Liwen
    Zheng, Jinping
    [J]. NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2021, 31 (01)
  • [38] Cost-effectiveness of telemonitoring for high-risk pregnant women
    Buysse, Heidi
    De Moor, Georges
    Van Maele, Georges
    Baert, Erik
    Thienpont, Geert
    Temmerman, Marleen
    [J]. INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2008, 77 (07) : 470 - 476
  • [39] Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
    Mocellin, Simone
    Pasquali, Sandro
    Rossi, Carlo R.
    Nitti, Donato
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (07) : 493 - 501
  • [40] A Cost-effectiveness Analysis of Sunitinib vs. Interferon-alpha in Patient with Advanced Renal Cell Carcinoma in Japan
    Tomura, Kazuki
    Naito, Yuki
    Sunaga, Tomiko
    Kurihara, Tatsuya
    Usuda, Masahiro
    Nagatani, Akiko
    Ogawa, Yumiko
    Akiyama, Nao
    Sasaki, Haruaki
    Murata, Tatsunori
    Sakamaki, Hiroyuki
    Kogo, Mari
    Sasaki, Tadanori
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (11): : 1397 - 1407
12345